Merete Lund Hetland

Merete Lund Hetland

Clinical Professor

Member of:

  • Internal Medicine: Rheumatology


  1. 2022
  2. Published

    One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses

    Danish Rheumatology Database (DANBIO), D. R. D. (., Anti-RheumaticTherapy in Sweden/Swedish Rheumatology Quality (ARTIS/SRQ), A. I. S. R. Q. (., Center for Rheumatology Research (ICEBIO), C. F. R. R. (., Finnish Register of Biological Treatment (ROB-FIN), F. R. O. B. T. (. & Norwegian Antirheumatic Drug Register (NOR-DMARD), N. A. D. R. (., 2022, In: Arthritis Care and Research. 74, 5, p. 748-758 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Participant evaluation of a behavioral intervention targeting reduction of sedentary behavior in patients with rheumatoid arthritis: a mixed methods study

    Thomsen, T., Aadahl, Mette, Aabo, M. R., Beyer, N., Hetland, Merete Lund & Esbensen, Bente Appel, 2022, In: Disability and Rehabilitation. 21, p. 6382-6393 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

    Ørnbjerg, L. M., Linde, L., Georgiadis, S., Rasmussen, S. H., Lindström, U., Askling, J., Michelsen, B., Giuseppe, D. D., Wallman, J. K., Pavelka, K., Závada, J., Nissen, M. J., Jones, G. T., Relas, H., Pirilä, L., Tomšič, M., Rotar, Z., Geirsson, A. J., Gudbjornsson, B., Kristianslund, E. K. & 14 others, van sder Horst-Bruinsma, I., Loft, A. G., Laas, K., Iannone, F., Corrado, A., Ciurea, A., Santos, M. J., Santos, H., Codreanu, C., Akkoc, N., Gunduz, O. S., Glintborg, Bente, Østergaard, Mikkel & Hetland, Merete Lund, 2022, In: Seminars in Arthritis and Rheumatism. 56, 152081.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark

    Hellgren, K., Secher, A. E., Glintborg, Bente, Rom, A. L., Gudbjornsson, B., Michelsen, B., Granath, F. & Hetland, Merete Lund, 2022, In: Rheumatology. 61, 9, p. 3711-3722 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

    Michelsen, B., Georgiadis, S., Di Giuseppe, D., Loft, A. G., Nissen, M. J., Iannone, F., Pombo-Suarez, M., Mann, H., Rotar, Z., Eklund, K. K., Kvien, T. K., Santos, M. J., Gudbjornsson, B., Codreanu, C., Yilmaz, S., Wallman, J. K., Brahe, C. H., Möller, B., Favalli, E. G., Sánchez-Piedra, C. & 13 others, Nekvindova, L., Tomsic, M., Trokovic, N., Kristianslund, E. K., Santos, H., Löve, T. J., Ionescu, R., Pehlivan, Y., Jones, G. T., van der Horst-Bruinsma, I., Ørnbjerg, L. M., Østergaard, Mikkel & Hetland, Merete Lund, 2022, In: Arthritis Care and Research. 74, 7, p. 1205-1218 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Rheumatology: biosimilars are here to stay

    Hetland, Merete Lund, 2022, In: Rheumatology. 61, 4, p. 1312-1313 2 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  8. Published

    Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark

    Secher, A. E. P., Granath, F., Glintborg, Bente, Rom, A., Hetland, Merete Lund & Hellgren, K., 2022, In: RMD Open. 8, 2, e002445.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial

    Lend, K., van Vollenhoven, R. F., Lampa, J., Hetland, Merete Lund, Haavardsholm, E. A., Nordström, D., Nurmohamed, M., Gudbjornsson, B., Rudin, A., Østergaard, Mikkel, Uhlig, T., Grondal, G., Hørslev-Petersen, K., Heiberg, M. S., Sokka-Isler, T., Koopman, F. A., Twisk, J. W. R. & van der Horst-Bruinsma, I., 2022, In: The Lancet Rheumatology. 4, 10, p. e688-e698

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries

    Delcoigne, B., Ljung, L., Provan, S. A., Glintborg, Bente, Hetland, Merete Lund, Grøn, K. L., Peltomaa, R., Relas, H., Turesson, C., Gudbjornsson, B., Michelsen, B. & Askling, J., 2022, In: Annals of the Rheumatic Diseases. 81, 6, p. 789-797 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    T-cell immunoglobulin and mucin domain 3 is upregulated in rheumatoid arthritis, but insufficient in controlling inflammation

    Skejoe, C., Hansen, A. S., Stengaard-Pedersen, K., Junker, P., Hoerslev-Pedersen, K., Hetland, Merete Lund, Østergaard, Mikkel, Greisen, S., Hvid, M., Deleuran, M. & Deleuran, B., 2022, In: American journal of clinical and experimental immunology. 11, 3, p. 34-44 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...3 4 5 6 7 8 9 10 ...46 Next

ID: 922207